Hony Capital invests in Biosensors PIPE

The China-focused firm will become the largest shareholder of the Singapore-listed medical device manufacturer, acquiring a 29.47% stake for about S$283.8m.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this